Dorling Janet 4
4 · CymaBay Therapeutics, Inc. · Filed Jan 27, 2022
Insider Transaction Report
Form 4
Dorling Janet
Chief Commercial Officer
Transactions
- Award
Stock Option (right to buy)
2022-01-25+67,000→ 67,000 totalExercise: $2.94Exp: 2032-01-24→ Common Stock (67,000 underlying)
Footnotes (1)
- [F1]The option vests as to 1/12 of the underlying shares monthly from January 1, 2022.